“…The Beers Criteria has been studied extensively in the U.S. and the STOPP/START Criteria has been studied in a variety of settings across Europe; but minimally in the U.S. (Cahir et al, 2010;O'Mahony, Gallagher, Byrne, Hamilton, Barry, O'Connor, Kennedy, 2010;Vishwas, Harugeri, Parthasarathi, Ramesh, 2012;Ryan, O'Mahony, Kennedy, Weedle, Byrne, 2009;Pham & Dickman, 2007;Shahezwan et al, 2012;Ramaswamy et al, 2010;Fick & Semla, 2012;Resnick & Pacala, 2012;Gallagher et al 2008;Lang Hasso, Belmin, Payot, Baeyens, Vogt-Ferrier, Gallagher, O'Mahony, Michel, 2009, Cherubini et al, 2012Ubeda, Ferrandiz, Maicas, Gomez, Bonet, Peris, 2012, Windsant-van The previous studies were conducted in European settings. Few studies have examined the STOPP/START Criteria in the U.S., Brahmbhatt and colleagues (2013) applied the STOPP/START Criteria in the U.S. and found a significant decrease in the number of medications triggered as inappropriate after initial and follow-up application of the criteria.…”